Zoetis (ZTS)
(Delayed Data from NYSE)
$193.59 USD
+0.95 (0.49%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $193.56 -0.03 (-0.02%) 5:42 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$193.59 USD
+0.95 (0.49%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $193.56 -0.03 (-0.02%) 5:42 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Zacks News
Corcept (CORT) Moves 6.5% Higher: Will This Strength Last?
by Zacks Equity Research
Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zoetis Stock Rises 15% in 3 Months: Time to Add to Your Portfolio?
by Zacks Equity Research
ZTS' innovative pet care products, along with efforts to expand the business, are expected to fuel significant growth in the future.
Zoetis (ZTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
In the most recent trading session, Zoetis (ZTS) closed at $191.09, indicating a +0.2% shift from the previous trading day.
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
by Zacks Equity Research
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for SAP, Cisco & Intuit
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Cisco Systems, Inc. (CSCO) and Intuit Inc. (INTU), as well as two micro-cap stocks Team, Inc. (TISI) and Miller Industries, Inc. (MLR)
Should You Invest in the VanEck Agribusiness ETF (MOO)?
by Zacks Equity Research
Sector ETF report for MOO
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zoetis (ZTS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Zoetis (ZTS) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
Zoetis (ZTS) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Zoetis (ZTS) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised
by Zacks Equity Research
Zoetis (ZTS) reports better-than-expected Q2 results, beating both earnings and revenue estimates, primarily driven by strong sales of companion animal products. Management raises the 2024 outlook.
Tech Giants Lead Market Selloff
by Zacks Equity Research
Tech Giants Lead Market Selloff
U.S. Stock Futures in Green After Three Days of Devastation
by Zacks Equity Research
U.S. Stock Futures in Green After Three Days of Devastation.
Zoetis (ZTS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Zoetis (ZTS) delivered earnings and revenue surprises of 4.70% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
UTHR or ZTS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UTHR vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the most recent trading session, Zoetis (ZTS) closed at $182.42, indicating a +1.32% shift from the previous trading day.
Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Xeris Biopharma (XERS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Zoetis (ZTS) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Zoetis (ZTS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the second quarter of 2024 in both the United States and International segments.
Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Zoetis (ZTS) reachead $179.84 at the closing of the latest trading day, reflecting a -0.51% change compared to its last close.
USNA vs. ZTS: Which Stock Is the Better Value Option?
by Zacks Equity Research
USNA vs. ZTS: Which Stock Is the Better Value Option?